2-Cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 10, 1996, Pages 1163-1166

  Ashworth, Doreen M ^a   Atrash, Butrus ^a   Baker, Graham R ^a   Baxter, Andrew J ^a   Jenkins, Paul D ^a   Jones, D Michael ^a   Szelke, Michael ^a  

^a Ferring Research Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANOPYRROLIDIDE DERIVATIVE; BORONIC ACID DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; IMMUNOMODULATING AGENT; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; T LYMPHOCYTE;

EID: 0029992827     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00190-4     Document Type: Article

References (19)

1. Heins, J., Weiker, P., Schonlein, C., Born, I., Hartrodt, B., Neubert, K., Tsuru, D. and Barth, A., Biochim. et Biophys. Acta 1988, 954, 161.
2. Hegen, M., Niedobitek, G., Clein, C.E., Stein, H. and Fleischer, B., J. Immunol. 1990, 144, 2908.
3. Buhling, F., Kunz, D., Rheinhold, D., Ulmer, A.J., Ernst, M., Flad, H.-D. and Ansorge, S., Nat. Immun. 1994, 13, 270.
4. Buhling, F., Junker, D., Rheinhold, D., Neubert, K., Jager, L. and Ansorge, S., Immunology Lett. 1995, 45, 47.
5. A review has recently been published, discussing the evidence that CD26 has important functions in the immune system. Fleischer, B., Immunology Today 1994, 15, 180.
6. Schon, E., Born, I., Demuth, H.-U., Faust, J., Neubert, K., Steinmetzer, T., Barth, A. and Ansorge, S., Biol. Chem. Hoppe-Seyler 1991, 372, 305.
7. Flentke, G.R., Munoz, E., Huber, B.T., Plaut, A.G., Kettner, C.A. and Bachovchin, W.W., Proc. Natl. Acad. Sci. USA 1991, 88, 1556.
8. Sudmeier, J.L., Gunther, U.L., Gutheil, W.G., Coutts, S.J., Snow, R.J., Barton, R.W. and Bachovchin, W.W., Biochemistry 1994, 33, 12427.
9. Bodusek, B., Oleksyszyn, J., Kam, C-M., Smith, R.E. and Powers, J.C., J. Med. Chem. 1994, 37, 3969.
10. Belyaev, A., Borloo, M., Augustyns, K., Lambeir, A.-M., De Meesters, I., Scharpe, S., Blaton, N., Peeters, O.M., De Ranter, C. and Haemers, A., Tetrahedron Lett. 1995, 36, 3755.
11. Borloo, M., Augustyns, K., Belyaev, A., De Meester, I., Lambeir, A.-M., Goossens, F., Bollaet, W., Rajan, P, Scharpe, S. and Haemers, A., Letts. in Pep. Sci. 1995, 2, 198.
12. Demuth, H.-U., Fischer, G., Barth, A. and Schowen, R.L., J. Org. Chem. 1988, 54, 5880.
13. i values were determined using Dixon plots.
14. Patent. WO 91/18877 (7 June 1990).
15. Patent. WO 95/15309 (6 Dec. 1993).
16. Li, J., Wilk, E. and Wilk, S., Arch. Biochem. and Biophys. 1995, 323, 148.
17. Schroder, E. and Lubke, K., The Peptides, Academic Press, New York, 1965, Vol. 1.
18. Martinez, J., Bali, J.P., Rodriguez, M., Castro, B., Laur, J. and Lignon, M.-F., J. Med. Chem. 1988, 28, 1874.
19. The stability of the inhibitors in buffered, aqueous solution (100 mM Tris, pH 7.4) was monitored by reverse-phase HPLC.